the world health organization (who) has suspended trials of hydroxychloroquine as a possible means from coronavirus infections, reports Reuters words of the Director-General of Tedros of Hebraicus.
the Test will not be conducted until then, until the Council of safety of chemical products not analyze data on the drug, he said. The pause in the test will relate only to hydroxychloroquine, other projects who find a cure COVID-19 will be implemented in the future.
Informed about the dangers of self administration of the drug, said the office of the food and drug administration (FDA) — hydroxychloroquine may cause arrhythmia, tachycardia and complications that lead to death.
last week the medical journal Lancet published a new study about the effectiveness of hydroxychloroquine: the authors argue that 15 000 patients COVID-19 who took the drug, the risk of death was higher than in those who were treated without it. After that, the researchers of the Institute of Raymond Poincare in France withdrew from publication his work on the treatment COVID-19 antimalarial drugs, according to Bloomberg.
Hydroxychloroquine intended for the treatment of malaria, but scientists are studying its potential for treating COVID-19. Clinical trials are held from March in the US, the UK, Spain and other countries, Russian Ministry of health also recommended the use of hydroxychloroquine in the treatment of patients with coronavirus.
